JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

C6372 Velpatasvir

Summary: An NS5A inhibitor for the treatment of chronic hepatitis C virus infection

≥146.66 mg/mL
B2009 Pranlukast

Summary: selective antagonist of the cysteinyl leukotrienes (LT) C(4), LTD(4) and LTE(4),

insoluble in EtOH; insoluble in H2O; ≥13.8 mg/mL
C6368 Delamanid

Summary: A mycobacterial cell wall synthesis inhibitor for the treatment of multidrug-resistant tuberculosis

insoluble in H2O; insoluble in EtOH; ≥24.9 mg/mL
B1980 Moroxydine HCl

Summary: synthetic antiviral compound

≥52.2 mg/mL
C6363 Fosfluconazole

Summary: An antifungal prodrug that inhibits fungal cell membrane synthesis

≥13.2 mg/mL
B1826 Risedronate

Summary: Farnesyl diphosphate (FPP) synthase inhibitor

insoluble in DMSO; insoluble in EtOH; insoluble in H2O
B1701 Chlorzoxazone

Summary: Muscle-relaxing drug
C5804 Latrunculin B

1 Citation

Summary: F-actin–destabilizing agent

≤25 mg/mL
C3486 Thymidine

Summary: pyrimidine nucleoside

≥24.2 mg/mL
A5293 Risedronate Sodium

Summary: A FPPS inhibitor

insoluble in EtOH; insoluble in DMSO; ≥10.17 mg/mL